Page 1 of Clinical Trials for Drug pemetrexed disodium, 419 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer
Last Updated: April 28, 2011
Condition(s): Cancer
2
Completed
A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
Last Updated: December 1, 2009
Condition(s): Ovarian Cancer; Peritoneal Cancer
3
Active, not recruiting
Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer
Last Updated: September 22, 2011
Condition(s): Lung Cancer
4
Recruiting
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
Last Updated: June 23, 2011
Condition(s): Lymphoma
5
Active, not recruiting
Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment
Last Updated: January 19, 2012
Condition(s): Lung Cancer
6
Recruiting
Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer
Last Updated: April 13, 2012
Condition(s): Advanced Cancers
7
Completed
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
Last Updated: November 10, 2011
Condition(s): Advanced Solid Tumours; Cancer; Lung Cancer, Non-Small Cell
8
Active, not recruiting
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Last Updated: May 22, 2012
Condition(s): Carcinoma, Non-Small-Cell Lung
9
Recruiting
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
Last Updated: September 9, 2011
Condition(s): Malignant Mesothelioma
10
Completed
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
Last Updated: January 22, 2009
Condition(s): Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Lung Cancer
11
Active, not recruiting
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer
Last Updated: March 10, 2012
Condition(s): Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer
12
Terminated
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Last Updated: March 2, 2011
Condition(s): Esophageal Neoplasms
13
Recruiting
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Last Updated: January 18, 2011
Condition(s): Breast Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Lung Cancer; Ovarian Cancer; Prostate Cancer
14
Completed
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Last Updated: September 9, 2011
Condition(s): Lung Cancer
15
Completed
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Last Updated: March 8, 2012
Condition(s): Mesothelioma
16
Completed
Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy
Last Updated: June 20, 2007
Condition(s): Non-Small Cell Lung Cancer
17
Recruiting
Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
Last Updated: April 18, 2012
Condition(s): Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity
18
Recruiting
Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer
Last Updated: April 19, 2012
Condition(s): Cancer
19
Active, not recruiting
Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer
Last Updated: May 4, 2012
Condition(s): Lung Cancer
20
Completed
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor
Last Updated: March 30, 2012
Condition(s): Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+pemetrexed+disodium

Page 1 of Clinical Trials for Drug pemetrexed disodium, 419 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About